- Home
- XENE vs G Comparison
XENE vs G Comparison
Compare XENE & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | G |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | Canada | Bermuda |
| Employees | N/A | 140000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.7B |
| IPO Year | 2014 | 2007 |
Fundamental Metrics
Financial Performance| Metric | XENE | G |
|---|---|---|
| Price | $39.54 | $34.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $68.55 | $49.50 |
| AVG Volume (30 Days) | 589.1K | ★ 2.2M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.21% |
| EPS Growth | N/A | ★ 9.82 |
| EPS | N/A | ★ 1.71 |
| Revenue | $311,000.00 | ★ $2,279,438,000.00 |
| Revenue This Year | N/A | $9.20 |
| Revenue Next Year | $2,496.48 | $7.27 |
| P/E Ratio | ★ N/A | $20.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.97 | $26.85 |
| 52 Week High | $72.66 | $48.64 |
Technical Indicators
Market Signals| Indicator | XENE | G |
|---|---|---|
| Relative Strength Index (RSI) | 14.04 | 43.03 |
| Support Level | N/A | $33.97 |
| Resistance Level | $45.39 | $35.09 |
| Average True Range (ATR) | 1.80 | 1.00 |
| MACD | -1.31 | -0.39 |
| Stochastic Oscillator | 2.10 | 4.60 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About G Genpact Limited
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.